Novo Holdings' earnings nearly doubled in 2024, despite Novo Nordisk's stock slump
Novo Holdings, the controlling shareholder of Ozempic-maker Novo Nordisk (NVO), nearly doubled its annual income and investment returns in 2024.Read more...
Novo Nordisk hands shelved Parkinson’s cell therapy to Zuckerberg-backed
<img src="https://media.thenextweb.com/2026/05/Novo-Nordisk.avif" width="868" height="488"><br /><p>Novo will take an equity stake in Cellular Intellige [...]
Anthropic says Claude Code transformed programming. Now Claude Cowork is co
<p><a href="https://www.anthropic.com/">Anthropic</a> opened its virtual "<a href="https://www.anthropic.com/events/the-briefing-enterprise-agents"> [...]